Blog Immunotherapy 360: irAEs

irAEs

The Immunotherapy 360 blog space features articles that encompass prominent issues related to immunotherapy. These are written with the assistance of the staff at AIM at Melanoma, AIM with Immunotherapy and health care practitioners.

If you have an idea for a future article, please reach out to us on our contact page!

Featured image for “Observations Learned from Steroid Use to Manage Immune-Related Adverse Events (irAEs)”

Observations Learned from Steroid Use to Manage Immune-Related Adverse Events (irAEs)

August 6, 2025
Helping an individual’s immune system to re-recognize and identify cancer cells has proven to be the most effective drug strategy…
Featured image for “Experiencing the Worst Effects Indicates the Best News for Patients”

Experiencing the Worst Effects Indicates the Best News for Patients

June 4, 2025
The silver lining for patients experiencing side effects related to immunotherapy and targeted therapy for cancer treatment is that these…

Recent Posts

Featured image for “Cylembio + Pembrolizumab Shows PFS Benefit in Advanced Melanoma Phase 3 Trial”
Aug. 11, 2025

Cylembio + Pembrolizumab Shows PFS Benefit in Advanced Melanoma Phase 3 Trial

Featured image for “Observations Learned from Steroid Use to Manage Immune-Related Adverse Events (irAEs)”
Aug. 06, 2025

Observations Learned from Steroid Use to Manage Immune-Related Adverse Events (irAEs)

Featured image for “Experiencing the Worst Effects Indicates the Best News for Patients”
Jun. 04, 2025

Experiencing the Worst Effects Indicates the Best News for Patients

Post Categories